Clinical Trial Update: Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of cisplatin, temozolomide, Abraxane with interleukin-2 and interferon for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)
• Interferon (interferon)
• Interleukin-2 (interleukin-2)
• Temozolomide (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1 | Status: COMPLETED